Ascendis Pharma A/S - ADR

+4.39 (+3.10%)
Earnings Announcements

Ascendis Pharma Posts Q3 Loss Per Share Of EUR 1.47

Published: 11/10/2021 21:51 GMT
Ascendis Pharma A/S - ADR (ASND) - Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share EUR 1.47.
Q3 Revenue EUR 1.1 Million Versus EUR 2.8 Million.
Q3 Earnings per Share View EUR -2.29, Revenue View EUR 1.1 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $3.99 Million
Adjusted EPS is expected to be -$2.58

Next Quarter Revenue Guidance is expected to be $10.77 Million
Next Quarter EPS Guidance is expected to be -$2.35

More details on our Analysts Page.